Bristol-Myers Squibb Company recalls

Bristol-Myers Squibb Company recalls Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only,

Bristol Myers Squibb recalls Opdualag (nivolumab and relatlimab-rmbw) injection vials with lack of sterility assurance. This recall affects single-dose vials sold between 2023 and 2026. No remedy is specified in the official notice.

Bristol-myers Squibb Company recalls EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and

Bristol-myers Squibb Company recalls BiCNU (Carmustine for injection) 100 mg and Diluent Rx Only BiCNU manufactured by: Ben Venue Laboratories, Inc.

Bristol-myers Squibb Company recalls Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-Not For Sale, 6 Tablets per

Bristol-myers Squibb Company recalls Kombiglyze XR (saxagliptin and metformin HCl extended-release) tablets, Physician Sample-Not For Sale, 7 Tablets per